AnaptysBio, Inc.ANABNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
242.81%
↑ 1028% above average
Average (39q)
21.52%
Historical baseline
Range
High:426.53%
Low:-100.00%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 242.81% |
| Q2 2025 | -19.83% |
| Q1 2025 | -35.59% |
| Q4 2024 | 43.63% |
| Q3 2024 | 173.60% |
| Q2 2024 | 52.82% |
| Q1 2024 | -20.28% |
| Q4 2023 | 171.40% |
| Q3 2023 | -4.10% |
| Q2 2023 | 151.82% |
| Q1 2023 | -79.82% |
| Q4 2022 | 426.53% |
| Q3 2022 | 6.33% |
| Q2 2022 | 25.36% |
| Q1 2022 | -4.06% |
| Q4 2021 | -95.16% |
| Q3 2021 | -30.43% |
| Q2 2021 | 166.98% |
| Q1 2021 | -81.25% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | -100.00% |
| Q1 2020 | 400.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | -100.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | -100.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -100.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | -100.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | -100.00% |
| Q4 2016 | -14.31% |
| Q3 2016 | -45.06% |
| Q2 2016 | 20.22% |
| Q1 2016 | 20.03% |
| Q4 2015 | -10.67% |